Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9713459
Method and system for in vivo hydrogen peroxide detection with ultrasound
granted -
US 9713628
Transplantation of neural cells
granted -
US 9713607
Salinosporamides and methods of use thereof
granted -
US 9708247
Modulators of the eIF2alpha pathway
granted -
US 9707284
Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases
granted -
US 9700596
Locally released growth factors to mediate motor recovery after stroke
granted -
US 9700519
Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
granted -
US 9700620
Polymeric nanocarriers with light-triggered release mechanism
granted -
US 9700708
Maintaining multiple defined physiological zones using model predictive control
granted -
US 9701675
Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
granted -
US 9695251
Activatable cell penetrating peptides with quenched fluorophores
granted -
US 9694047
Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
granted -
US 9694074
Functionalized porous silicon nanoparticles and use thereof in photodynamic therapy
granted -
US 9695249
Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
granted -
US 9688673
Deoxycytidine kinase binding compounds
granted -
US 9689042
Use of glycolytic pathways for inhibiting or measuring oncogenic signaling
granted -
US 9687553
Polymeric nanocarriers with linear dual response mechanism
granted -
US 9682106
Method for combined conditioning and chemoselection in a single cycle
granted -
US 9683009
Bone-selective osteogenic oxysterol-bone targeting agents
granted -
US 9682151
Peptides whose uptake in cells is controllable
granted -
US 9675649
Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
granted -
US 9675591
Methods for treating seizure disorders and pain
granted -
US 9678060
Lunasin-induced regulation of disease-related gene expression
granted -
US 9669098
Metal-organic frameworks with exceptionally large pore aperatures
granted